Melphalan pharmacokinetics and transplant related toxicity during autologous stem cell transplantation

Affiliations

¹ Hematology and Bone Marrow Transplantation Unit, Medicana International Ankara Hospital, Ankara, Turkey. ugursahin_dr@yahoo.com.
² Hematology and Bone Marrow Transplantation Unit, Medicana International Ankara Hospital, Ankara, Turkey.
³ Department of Hematology, Faculty of Medicine, Ankara University, Ankara, Turkey.

Comment

Ugur Sahin et al. Bone Marrow Transplant. 2021 Jan.

. 2021 Jan;56(1):7-8.

doi: 10.1038/s41409-020-01043-6. Epub 2020 Aug 26.

¹ Hematology and Bone Marrow Transplantation Unit, Medicana International Ankara Hospital, Ankara, Turkey. ugursahin_dr@yahoo.com.
² Hematology and Bone Marrow Transplantation Unit, Medicana International Ankara Hospital, Ankara, Turkey.
³ Department of Hematology, Faculty of Medicine, Ankara University, Ankara, Turkey.

No abstract available

Comment on

Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis.
Vaxman I, Sidiqi MH, Al Saleh AS, Kumar S, Muchtar E, Dispenzieri A, Buadi F, Dingli D, Lacy M, Hayman S, Leung N, Gonsalves W, Kourelis T, Warsame R, Hogan W, Gertz M. Vaxman I, et al. Bone Marrow Transplant. 2021 Apr;56(4):928-935. doi: 10.1038/s41409-020-01136-2. Epub 2020 Nov 18. Bone Marrow Transplant. 2021. PMID: 33208916

1. Al Saleh AS, Sidiqi MH, Lee J, Dispenzieri A, Muchtar E, Buadi FK, et al. Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant. Bone Marrow Transplant. 2020. https://doi.org/10.1038/s41409-020-0916-3 . - DOI - PubMed
1. Alberts DS, Chang SY, Chen HS, Moon TE, Evans TL, Furner RL, et al. Kinetics of intravenous melphalan. Clin Pharm Ther. 1979;26:73–80. https://doi.org/10.1002/cpt197926173 . - DOI
1. Samuels BL, Bitran JD. High-dose intravenous melphalan: a review. J Clin Oncol. 1995;13:1786–99. https://doi.org/10.1200/JCO.1995.13.7.1786 . - DOI - PubMed
1. GlaxoSmithKline. ALKERAN® (melphalan hydrochloride) for injection prescribing information. U.S. Food and Drug Administration. 2011. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020207s016lbl.pdf . Accessed 15 Jun 2020.
1. Spectrum Pharmaceuticals, Inc. EVOMELA® (melphalan) for injection, for intravenous use full prescribing information. U.S. Food and Drug Administration. 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207155s001lbl.pdf . Accessed 15 Jun 2020.